Metastatic Chemotherapy Resistant Urothelial Carcinoma (UC): Next Generation Sequencing (NGS) Reveals a Diverse Spectrum of Genomic Alterations (GA) and Targets of Therapy

被引：0
|
作者：
Ross, J. S.
Nazeer, T.
Sheehan, C. E.
Palmer, G.
Otto, G.
Downing, S.
Curran, J.
Yelensky, R.
Lipson, D.
Balasubramanian, S.
Garcia, L.
Mahoney, K.
Stephens, P.
Miller, V.
机构：
[1] Albany Med Ctr, Albany, NY USA
[2] Fdn Med Inc, Cambridge, MA USA
来源：
LABORATORY INVESTIGATION | 2013年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1013
引用
收藏
页码：244A / 244A
页数：1
相关论文
共 33 条
  • [1] Metastatic Chemotherapy Resistant Urothelial Carcinoma (UC): Next Generation Sequencing (NGS) Reveals a Diverse Spectrum of Genomic Alterations (GA) and Targets of Therapy
    Ross, J. S.
    Nazeer, T.
    Sheehan, C. E.
    Palmer, G.
    Otto, G.
    Downing, S.
    Curran, J.
    Yelensky, R.
    Lipson, D.
    Balasubramanian, S.
    Garcia, L.
    Mahoney, K.
    Stephens, P.
    Miller, V.
    MODERN PATHOLOGY, 2013, 26 : 244A - 244A
  • [2] Advanced urothelial carcinoma: next-generation sequencing reveals diverse genomic allterations and targets of therapy
    Ross, Jeffrey S.
    Wang, Kai
    Al-Rohil, Rami N.
    Nazeer, Tipu
    Sheehan, Christine E.
    Otto, Geoff A.
    He, Lie
    Palmer, Gary
    Yelensky, Roman
    Lipson, Doron
    Ali, Siraj
    Balasubramanian, Sohail
    Curran, John A.
    Garcia, Lazlo
    Mahoney, Kristen
    Downing, Sean R.
    Hawryluk, Matthew
    Miller, Vincent A.
    Stephens, Philip J.
    MODERN PATHOLOGY, 2014, 27 (02) : 271 - 280
  • [3] Comparison of Genomic Alterations in Urothelial Carcinoma (UC) with and without TERT Promoter Mutation Using a Next-Generation Sequencing (NGS) Assay
    Al-Ahmadie, Hikmat
    Sumit, Isharwal
    Audenet, Francois
    Pietzak, Eugene J.
    Cha, Eugene K.
    Gopalan, Anuradha
    Chen, Ying-Bei
    Sirintrapun, Joseph S.
    Fine, Samson W.
    Tickoo, Satish K.
    Reuter, Victor E.
    Rosenberg, Jonathan E.
    Bochner, Bernard H.
    Bajorin, Dean F.
    Zehir, Ahmet
    Taylor, Barry S.
    Berger, Michael F.
    Iyer, Gopa
    Solit, David
    LABORATORY INVESTIGATION, 2017, 97 : 211A - 211A
  • [4] Comparison of Genomic Alterations in Urothelial Carcinoma (UC) with and without TERT Promoter Mutation Using a Next-Generation Sequencing (NGS) Assay
    Al-Ahmadie, Hikmat
    Sumit, Isharwal
    Audenet, Francois
    Pietzak, Eugene J.
    Cha, Eugene K.
    Gopalan, Anuradha
    Chen, Ying-Bei
    Sirintrapun, Joseph S.
    Fine, Samson W.
    Tickoo, Satish K.
    Reuter, Victor E.
    Rosenberg, Jonathan E.
    Bochner, Bernard H.
    Bajorin, Dean F.
    Zehir, Ahmet
    Taylor, Barry S.
    Berger, Michael F.
    Iyer, Gopa
    Solit, David
    MODERN PATHOLOGY, 2017, 30 : 211A - 211A
  • [5] NEXT GENERATION SEQUENCING OF CELL FREE DNA REVEALS GENOMIC ABERRATIONS IN METASTATIC UROTHELIAL CARCINOMA
    Todenhofer, Tilman
    Volik, Stanislav
    Eigl, Bernie
    North, Scott
    Brahmbhatt, Sonal
    Haegert, Anne
    Mischinger, Johannes
    Stenzl, Arnulf
    LeBihan, Stephane
    Wyatt, Alexander
    Collins, Colin
    Black, Peter
    JOURNAL OF UROLOGY, 2016, 195 (04): : E664 - E664
  • [6] Clinical next-generation sequencing (NGS) reveals genomic alterations (GAs) to guide targeted therapy in advanced neuroblastoma patients
    Ali, Siraj M.
    Hawryluk, Matthew J.
    Wang, Kai
    Chmielecki, Juliann
    Palmer, Gary A.
    Garcia, Lazaro
    White, Emily
    Yelensky, Roman
    Stephens, Philip J.
    Ross, Jeffrey S.
    Marls, John M.
    Miller, Vince A.
    CANCER RESEARCH, 2014, 74 (20)
  • [7] Genomic profiling using a clinical next generation sequencing (NGS) assay reveals genomic alterations to guide targeted therapy in advanced neuroblastoma patients
    Ali, S.
    Sanford, E. M.
    Hawryluk, M. J.
    Chmielecki, J.
    Wang, K.
    Palmer, G. A.
    Palma, N. A.
    Morosini, D.
    Erlich, R.
    Yelensky, R.
    Lipson, D.
    Ross, J. S.
    Mosse, Y.
    Stephens, P. J.
    Maris, J. M.
    Miller, V. A.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 132 - 132
  • [8] Next-Generation Sequencing Reveals Potential Predictive Biomarkers and Targets of Therapy for Urothelial Carcinoma in Situ of the Urinary Bladder
    Garczyk, Stefan
    Ortiz-Bruechle, Nadina
    Schneider, Ursula
    Lurje, Isabella
    Guricova, Karolina
    Gaisa, Nadine T.
    Lorsy, Eva
    Lindemann-Docter, Katharina
    Heidenreich, Axel
    Knuechel, Ruth
    AMERICAN JOURNAL OF PATHOLOGY, 2020, 190 (02): : 323 - 332
  • [9] NEXT-GENERATION SEQUENCING REVEALS GENOMIC DIFFERENCES BETWEEN MALE AND FEMALE PATIENTS WITH UROTHELIAL CARCINOMA
    Walasek, Aleksandra
    Wankel, Bret
    Almassi, Nima
    Teo, Min Yuen
    Funt, Samuel
    Schultz, Nikolaus
    Dalbagni, Guido
    Hu, Wenhu
    Al-Ahmadie, Hikmat
    Furberg-Barnes, Helena
    Petruzella, Stacey
    Bajorin, Dean
    Rosenberg, Jonathan
    Iyer, Gopakumar
    Bochner, Bernard
    Solit, David
    Pietzak, Eugene
    JOURNAL OF UROLOGY, 2019, 201 (04): : E901 - E902
  • [10] Genomic alterations in 670 patients with diverse cancers analyzed by next-generation sequencing (NGS) of circulating tumor DNA (ctDNA).
    Schwaederle, Maria Clemence
    Chattopadhyay, Ranajoy
    Kato, Shumei
    Fanta, Paul T.
    Banks, Kimberly
    Piccioni, David Eric
    Ikeda, Sadakatsu
    Talasaz, AmirAli
    Lanman, Richard B.
    Bazhenova, Lyudmila
    Kurzrock, Razelle
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
1234